moderna

Vaccines Battle: Moderna Gears Up for RSV Approval Against Pfizer and GSK – Will They Dominate?

by

Boston, MA – Vaccines have been at the forefront of medical innovation in recent years, with the approval of new shots offering hope for tackling a range of diseases. Moderna, a biotech company based in Boston, Massachusetts, has recently received approval for its shot targeting respiratory syncytial virus (RSV) in older adults. This approval marks a significant step in the company’s efforts to expand its messenger RNA platform beyond just Covid treatments. The Centers for …

Read more

Approval Imminent: Moderna Set to Launch RSV Shot in U.S. Market After Success of Covid Vaccine

by

Boston, Massachusetts – Moderna is on the cusp of an important milestone as investors eagerly await the approval of its RSV vaccine, marking a potential comeback from its struggles during the COVID-19 pandemic last year. The company’s RSV shot, if authorized, would be its second product to enter the market in the United States following the success of its COVID-19 vaccine. This would also make Moderna the third company to introduce an RSV vaccine, after …

Read more

Vaccines Day: Moderna Reveals Breakthrough Data on 3 New Shots, Including Norovirus, Epstein-Barr, and Shingles – What You Need to Know Now!

by

Boston, MA – Moderna recently announced positive data from clinical trials on three new experimental vaccines, showcasing the company’s efforts to expand beyond its well-known Covid vaccine. These vaccines are now moving towards final stages of study, marking a significant step towards diversifying Moderna’s product portfolio. The update comes at a crucial time for the company, given the decline in demand for Covid shots worldwide. With its Covid vaccine being the only product commercially available, …

Read more

Stocks to Watch: Nvidia, Moderna, and More Surge in Premarket Trading – Find Out Which Companies are Making Big Moves Before the Bell!

by

New York, NY – Wall Street saw significant premarket movement from several companies after the release of their earnings reports. Nvidia led the surge with a 13% increase after their earnings announcement beat expectations, driven by the artificial intelligence boom. Moderna also experienced a rise of more than 5% following their fourth-quarter revenue report, surpassing analysts’ forecasts. On the other hand, luxury electric vehicle company Lucid saw a dip of more than 7% after missing …

Read more